Gene Query: HIBADH

Dataset Description Geneva Score
Role for citron kinase in prostate cancer growth 57.7
Control of prostate tumour growth by the long non-coding RNA GHSROS 37.42
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 34.93
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 27.4
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 26.92
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 25.13
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 25.06
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 24.92
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 24.4
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 23.19
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 20.94
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 20.23
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 19.18
Differentially expressed genes post knock down of lincDUSP26 19.03
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 19.02
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 18.8
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 18.0
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 17.25
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 16.65
RNA-seq analysis of uveal melanoma cells treated with FR900359 16.4
RNA-seq of human fibroblasts after irradiation 15.82
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 15.8
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 15.75
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 15.58
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 15.52
Primary human trophoblast from term placenta 15.35
Identifying the molecular mode of action of itraconazole in colorectal cancer 15.17
Uridylation by TUT4 and TUT7 marks mRNA for degradation 15.06
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 14.9
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 14.9
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 14.64
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 14.26
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 14.04
Role of CD133 molecule in WNT response and renal repair 14.03
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 14.03
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 14.02
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 13.88
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 13.88
Differential Gene Expression between MCF10A and MCF7 cells 13.88
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 13.83
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  13.63
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 13.61
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 13.51
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 13.5
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 13.1
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 12.89
Functional role of SLIT2 and ROBO1 in trophoblasts 12.76
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 12.68
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 12.68
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 12.59
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 12.54
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 12.18
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 11.98
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 11.98
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 11.6
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 11.59
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 11.44
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 11.35
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 11.3
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 11.28
A549 cells and MSR-A549 cells 11.28
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 11.08
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 10.92
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 10.91
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 10.84
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 10.79
Identification of Sin3B regulated genes during quiescence 10.76
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 10.68
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 10.58
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 10.58
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 10.34
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 10.34
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 10.32
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 10.29
MOF acetyl transferase regulates transcription and respiration in mitochondria 10.27
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 10.27
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 10.25
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 10.25
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 10.23
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 10.14
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 10.14
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 10.12
SOX11 knockdown in B-ALL cell lines 10.03
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 10.03
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 10.03
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 10.0
Effect of Influenza virus infection on lncRNA expression in A549 cells 9.97
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 9.92
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 9.8
RNA-seq of YB5 cells treated with Proscillaridin A 9.8
Single-nucleotide-resolution mapping of HBV promoters using CAGE 9.75
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 9.66
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 9.61
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 9.61
Ebola virus (EBOV) infection of ARPE-19 cells 9.6
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 9.55
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 9.55
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 9.12
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 9.01
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 9.0
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 8.98
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 8.89
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 8.89
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 8.86
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 8.86
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 8.85
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 8.85
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 8.76
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 8.74
RNA-seq analyses of human prostate cancer cells 8.71
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 8.69
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 8.65
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 8.61
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 8.59
ARS2 is a general suppressor of pervasive transcription [RNAseq] 8.58
Effect of disulfiram treatment on pediatric high grade glioma 8.56
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 8.48
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 8.45
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 8.45
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 8.44
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 8.43
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 8.37
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 8.37
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 8.37
Paxillin regulates genomic networks in prostate cancer [LNCaP] 8.36
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 8.26
Survival of pancreatic cancer cells lacking KRAS function 8.22
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 8.16
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 7.79
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 7.79
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 7.79
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 7.74
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 7.74
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 7.74
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 7.59
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 7.54
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 7.54
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 7.52
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 7.5
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 7.48
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 7.47
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 7.41
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 7.25
T47D RNA-seq and ChrRNA-seq data 7.25
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 7.15
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 7.13
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 7.11
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 7.11
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 7.11
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 7.1
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 7.1
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 7.07
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 7.07
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 7.02
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 6.97
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 6.95
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 6.94
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 6.93
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 6.89
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 6.86
RNAseq Study in CC-671 Treated Cal-51 Cells 6.8
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 6.74
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 6.74
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 6.67
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 6.65
The effect of Abl kinases on non-small cell carcinoma global transcriptome 6.61
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 6.55
NRDE2 negatively regulates nuclear exosome functions 6.54
FOXD3 is a novel tumor suppressor in lung cancer 6.52
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 6.51
Genome-wide functional assessment of enhancer activities in the human genome 6.5
Mitochondrial dsRNA triggers antiviral signalling in humans 6.45
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 6.43
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 6.41
Fbxo32 mediated gene expression program underlies EMT and metastasis 6.4
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 6.4
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 6.4
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 6.34
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 6.34
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 6.27
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 6.18
Global transcriptome analysis of HAP1 cells 6.16
Effect of CHKA knockdown on C4-2 cell transcriptome 6.14
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 6.11
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 6.09
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 6.09
Oncogenic MYC induces a dependency on the spliceosome in human cancer 6.09
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 6.06
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 6.02
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 5.95
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 5.94
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 5.94
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 5.91
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 5.9
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 5.89
Non-coding regions are the main source of tumor-specific antigens 5.86
Non-coding regions are the main source of tumor-specific antigens [human] 5.86
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 5.86
A sister of NANOG regulates genes expressed in pre-implantation human development 5.83
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 5.79
Effect of PBK knockdown on C4-2 cell transcriptome 5.78
Transcriptome analysis of virus infected tissues 5.74
IDH3a KO RNA-seq 5.72
Genome wide expression change in LCC2 and MCF-7 cells 5.71
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 5.7
Transcriptome landscape of HeLa response upon triamcinolone acetonide 5.66
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 5.65
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 5.65
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 5.63
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 5.63
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 5.63
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 5.62
Electronic cigarettes 5.61
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 5.58
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 5.58
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 5.55
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 5.55
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 5.5
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 5.49
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 5.48
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 5.48
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 5.47
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 5.47
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 5.45
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 5.44
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 5.43
RNAseq analysis of ESRP regulated splicing events in prostate cancer 5.41
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 5.41
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 5.41
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 5.41
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 5.38
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 5.38
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 5.37
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 5.32
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 5.32
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 5.32
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 5.29
A transcriptome-wide divergence in protein translation scales with LIN28B expression 5.21
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 5.19
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 5.18
Dtx3L and Androgen Signaling in Prostate Cancer 5.14
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 5.13
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 5.11
Selective expression of long non-coding RNAs in a breast cancer cell progression model 5.1
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 5.1
HNRNPM-regulated splicing dependencies in prostate cancer 5.1
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 5.09
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 5.08
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 5.08
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 5.07
RNA-seq of MDA-MB-231 cells with TET1 knockout 5.07
Transcriptomic and gene ontology profiling of the human corneal cell types 5.04
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 5.02
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 5.02
HNRNPL and its RNA Targets in Prostate Cancer 5.02
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 5.01
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 5.01
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 5.0
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 4.95
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 4.93
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 4.93
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 4.93
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 4.89
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 4.83
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 4.81
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 4.79
Cell responses to dysregulated VZV-induced cell-cell fusion 4.74
RNA-seq of cells with TET1 knockout 4.67
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 4.66
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 4.61
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 4.6
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 4.59
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 4.59
Evaluating pre-clinical models for studying NASH driven HCC. 4.58
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 4.52
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 4.52
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 4.52
RNA-seq analyisis of PUM2 knockout cells 4.52
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 4.5
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 4.47
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 4.46
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 4.43
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 4.43
Transcriptomic analysis of ERR alpha orphan nuclear receptor 4.39
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 4.38
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 4.37
DIGIT regulates endoderm differentiation of human embryonic stem cells 4.37
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 4.36
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 4.35
HBEC-shp53-PCHD7 4.34
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 4.33
Gene expression profile difference among renal location in a stone former 4.25
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 4.23
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 4.2
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 4.17
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 4.17
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 4.17
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 4.17
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 4.17
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 4.17
Lysine benzoylation is a novel histone mark [RNA-seq] 4.14
Lysine benzoylation is a novel histone mark 4.14
Paxillin regulates genomic networks in prostate cancer [C4-2] 4.13
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 4.11
RNA-seq analysis of the human fetal kidney. 4.03
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 4.02
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 4.01
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 3.97
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 3.97
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 3.92
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 3.87
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 3.77
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 3.77
An integrative analysis of non-coding regulatory DNA variations associated with autism 3.71
Epigenetic reprogramming of melanoma cells by vitamin C treatment 3.7
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 3.69
Characterization of parental and rociletinib-resistant derived H1975 cell lines 3.64
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 3.62
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 3.62
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 3.6
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 3.58
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 3.57
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 3.57
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 3.52
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 3.47
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 3.47
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 3.35
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 3.35
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 3.3
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 3.3
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 3.29
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 3.22
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 3.17
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 3.15
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 3.13
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 3.13
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 3.12
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 3.11
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 3.09
JunB control of keratinocyte-mediated inflammation [RNA-seq] 3.09
Single-cell analysis of human kidney organoids 3.08
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 3.07
RNA sequencing of human mammary epithelial cells 3.05
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 3.0
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  2.96
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.95
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 2.92
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 2.92
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 2.86
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 2.86
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 2.85
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 2.85
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 2.82
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 2.82
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 2.79
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 2.79
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 2.76
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 2.76
mRNA recovered upon RNF219 IP. [RNA-IP] 2.76
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 2.74
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 2.68
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 2.63
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.61
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 2.58
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 2.54
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 2.54
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 2.46
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 2.46
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 2.44
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 2.36
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 2.36
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 2.29
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 2.28
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 2.27
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 2.26
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 2.25
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 2.22
Repurposing of promoters and enhancers during mammalian evolution 2.22
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 2.21
N6-methyladenine DNA Modification in Glioblastoma 2.21
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 2.19
Efficient derivation of microglia-like cells from human pluripotent stem cells 2.18
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 2.15
Induced DNA demethylation, genome instability and transcription 2.15
m6A-dependent regulation of messenger RNA stability 2.14
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 2.13
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 2.09
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 2.09
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 2.08
Gene expression of collecting duct carcinoma of the kidney 2.08
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 2.07
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 2.06
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 2.06
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 2.05
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 2.05
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 2.02
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 1.99
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 1.97
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.97
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.94
Dilated cardiomyopathy vs Myocarditis 1.92
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.9
The circadian transcriptional landscape in primary human mammary epithelial cells 1.89
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 1.84
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 1.81
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 1.81
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 1.76
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 1.76
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 1.59
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 1.57
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.52
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 1.51
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 1.43
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.42
The role of the Calcium-Sensing receptor in colorectal cancer 1.42
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 1.32
CDK4/6 inhibitor resistance in prostate cancer 1.3
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.29
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 1.28
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 1.26
The effect of insulin on mRNA transcription of human pluripotent stem cells 1.21
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 1.21
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  1.2
Regulation of hypoxia-inducible factor activity by ZMYND8 1.2
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 1.16
Effect of nuclear IL-33 on gene expression 1.12
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.08
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 1.08
Triple vectors expand AAV transfer capacity in the retina 1.05
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 1.01
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 1.01
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 0.99
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.97
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.97
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 0.94
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.93
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.93
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.92
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 0.91
Random mono-allelic expression in MECP2-mutated cells 0.91
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.9
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 0.88
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.87
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.86
Expression charcaterization of an internal protocol developed to differentiate RPE cells 0.86
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.81
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 0.79
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.78
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 0.77
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 0.75
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 0.75
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.7
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.66
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.66
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.64
Identification of a LIF-responsive replication-competent human β cell 0.64
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.63
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.63
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.63
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 0.62
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 0.6
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 0.6
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 0.6
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 0.57
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.52
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.51
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 0.5
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.46
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 0.46
Modeling Human Cancer-induced Cachexia (Human) 0.44
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.39
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.36
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.31
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.31
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.3
Hepatocyte maturation 0.29
RNA-Seq and expression data from human adipose tissue 0.28
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.28
Preclinical model of obesity and ER-positive breast cancer 0.26
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.23
RNA Seq of Alagille liver biopsies 0.23
Alagille_Nodder 0.23
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.22
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.22
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.2
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.17
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 0.16
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.16
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 0.15
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 0.15
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 0.12
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 0.11
Transcriptomic analysis of LSD1 0.11
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.08
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.07
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.07
Effects of transcription on genome - nuclear lamina interactions 0.02
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.02
Transcriptome-wide modulation of splicing by the exon junction complex 0.02
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation